{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:54:08Z","timestamp":1780970048809,"version":"3.54.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To devise a simple PET-CT score for measurement of muscle disease activity in patients with inflammatory myopathies (IMs) and to assess its validity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 44 PET-CT examinations in 34 IM patients (performed during cancer screening) and 20 PET-CT examinations in matched controls (investigated for pulmonary nodules with a conclusion of benignity) were analysed. Maximal standardized uptake values (SUVmax) were recorded bilaterally in eight proximal muscles. The muscle SUVmax (mSUVmax) was defined as the average of the 16 muscle SUVmax values, normalized on the liver mean SUV. Reliability, validity and responsiveness were evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The mSUVmax was increased in IM patients compared with controls. This index allowed the identification of patients with high vs low muscle disease activity using the myositis intention to treat activity index as the gold standard. In patients with subsequent examinations, our method showed good accuracy to detect changes in muscle disease activity [area under the curve 0.96 (95% CI 0.84, 1)]. Responsiveness was strong. Interrater reliability was excellent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>PET-CT, a non-invasive tool useful for cancer screening, is also valuable to measure muscle disease activity and its evolution in IM patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kez040","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T04:07:34Z","timestamp":1548734854000},"page":"1459-1464","source":"Crossref","is-referenced-by-count":22,"title":["Muscle fluorodeoxyglucose uptake assessed by positron emission tomography\u2013computed tomography as a biomarker of inflammatory myopathies disease activity"],"prefix":"10.1093","volume":"58","author":[{"given":"Julien","family":"Matuszak","sequence":"first","affiliation":[{"name":"Biophysics and Nuclear Medicine Department, University Hospitals of Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Blondet","sequence":"additional","affiliation":[{"name":"Biophysics and Nuclear Medicine Department, University Hospitals of Strasbourg, Strasbourg, France"},{"name":"Federation of Translational Medicine of Strasbourg, Strasbourg University, Strasbourg, France"},{"name":"ICube Joint Research Unit 7357, Illkirch-Graffenstaden, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Hubel\u00e9","sequence":"additional","affiliation":[{"name":"Biophysics and Nuclear Medicine Department, University Hospitals of Strasbourg, Strasbourg, France"},{"name":"Federation of Translational Medicine of Strasbourg, Strasbourg University, Strasbourg, France"},{"name":"ICube Joint Research Unit 7357, Illkirch-Graffenstaden, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[{"name":"Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Sibilia","sequence":"additional","affiliation":[{"name":"Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bund","sequence":"additional","affiliation":[{"name":"Biophysics and Nuclear Medicine Department, University Hospitals of Strasbourg, Strasbourg, France"},{"name":"Federation of Translational Medicine of Strasbourg, Strasbourg University, Strasbourg, France"},{"name":"ICube Joint Research Unit 7357, Illkirch-Graffenstaden, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Geny","sequence":"additional","affiliation":[{"name":"Physiology and Functional Explorations Department, University Hospitals of Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izzie Jacques","family":"Namer","sequence":"additional","affiliation":[{"name":"Biophysics and Nuclear Medicine Department, University Hospitals of Strasbourg, Strasbourg, France"},{"name":"Federation of Translational Medicine of Strasbourg, Strasbourg University, Strasbourg, France"},{"name":"ICube Joint Research Unit 7357, Illkirch-Graffenstaden, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Meyer","sequence":"additional","affiliation":[{"name":"Federation of Translational Medicine of Strasbourg, Strasbourg University, Strasbourg, France"},{"name":"Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases"},{"name":"Physiology and Functional Explorations Department, University Hospitals of Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"2019072312202045900_kez040-B1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbspin.2017.03.005","article-title":"Inflammatory myopathies: a new landscape","volume":"85","author":"Meyer","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2019072312202045900_kez040-B2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"2019072312202045900_kez040-B3","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.30344","article-title":"Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy","volume":"63","author":"Benveniste","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2019072312202045900_kez040-B4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/keu422","article-title":"Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle","volume":"54","author":"Zheng","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2019072312202045900_kez040-B5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/annrheumdis-2012-202915","article-title":"Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis","volume":"73","author":"Malattia","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2019072312202045900_kez040-B6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00256-007-0323-5","article-title":"Whole-body imaging of the musculoskeletal system: the value of MR imaging","volume":"36","author":"Schmidt","year":"2007","journal-title":"Skeletal Radiol"},{"key":"2019072312202045900_kez040-B7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group\/Paediatric Rheumatology International Trials Organisation collaborative initiative","volume":"76","author":"Aggarwal","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2019072312202045900_kez040-B8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O\u2019Callaghan","year":"2010","journal-title":"Am J Med"},{"key":"2019072312202045900_kez040-B9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-1241.2008.01774.x","article-title":"Value of 18F-FDG-PET\/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience","volume":"64","author":"Federici","year":"2010","journal-title":"Int J Clin Pract"},{"key":"2019072312202045900_kez040-B10","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3899\/jrheum.111597","article-title":"Detection of inflammatory lesions by F-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis","volume":"39","author":"Owada","year":"2012","journal-title":"J Rheumatol"},{"key":"2019072312202045900_kez040-B11","first-page":"570","article-title":"18F-fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series","volume":"30","author":"Pipitone","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2019072312202045900_kez040-B12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3899\/jrheum.121092","article-title":"Is 18F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis?","volume":"40","author":"Pipitone","year":"2013","journal-title":"J Rheumatol"},{"key":"2019072312202045900_kez040-B13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","article-title":"[18F]FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2019072312202045900_kez040-B14","doi-asserted-by":"crossref","first-page":"e006763","DOI":"10.1136\/bmjopen-2014-006763","article-title":"Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation","volume":"5","author":"Tateyama","year":"2015","journal-title":"BMJ Open"},{"key":"2019072312202045900_kez040-B15","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-017-3794-3","article-title":"Multiple values of 18F-FDG PET\/CT in idiopathic inflammatory myopathy","volume":"36","author":"Li","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2019072312202045900_kez040-B16","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2019072312202045900_kez040-B17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"2019072312202045900_kez040-B18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"2019072312202045900_kez040-B19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00256-010-0930-4","article-title":"Morphologic imaging in muscular dystrophies and inflammatory myopathies","volume":"39","author":"Degardin","year":"2010","journal-title":"Skeletal Radiol"},{"key":"2019072312202045900_kez040-B20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0895-4356(03)00084-2","article-title":"A comparison of two time intervals for test-retest reliability of health status instruments","volume":"56","author":"Marx","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"2019072312202045900_kez040-B21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0272989X0002000410","article-title":"Determining the area under the ROC curve for a binary diagnostic test","volume":"20","author":"Cantor","year":"2000","journal-title":"Med Decis Making"},{"key":"2019072312202045900_kez040-B22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.1780280513","article-title":"Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research","volume":"28","author":"Liang","year":"1985","journal-title":"Arthritis Rheum"},{"key":"2019072312202045900_kez040-B23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.2011.06016.x","article-title":"PET\/CT imaging in inflammatory myopathies","volume":"1228","author":"Al-Nahhas","year":"2011","journal-title":"Ann N Y Acad Sci"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/58\/8\/1459\/28984678\/kez040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T17:09:41Z","timestamp":1563901781000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/58\/8\/1459\/5372754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":23,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,3,8]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kez040","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,3,8]]}}}